![]() |
市場調查報告書
商品編碼
1847180
美國麻醉、呼吸和睡眠管理設備市場:市場規模、佔有率和趨勢分析(2025-2031 年)Anesthesia, Respiratory & Sleep Management Devices Market Size, Share & Trends Analysis | United States | 2025-2031 | Includes: Anesthesia Delivery Units (ADUs), Ventilators, Nebulizers, and 8 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024年,美國麻醉、呼吸和睡眠管理設備市場價值約70億美元。預計在預測期內,該市場將接近90億美元。
本報告涵蓋麻醉輸送裝置、麻醉監控器、麻醉資訊管理系統、麻醉拋棄式、人工呼吸器、霧化器、呼吸拋棄式、氧氣療法設備、阻塞型睡眠呼吸中止症中止症治療設備、睡眠診斷設備和體外膜氧氣療法(ECMO)系統。
定量研究對象包括銷售量、平均售價、市場規模、成長率和企業市場占有率。
定性分析包括市場促進因素和阻礙因素、併購、產品系列、相關召回以及在醫院、門診手術中心和居家醫療的競爭定位。
市場概覽
人口結構變化和技術的普及持續影響著美國對 ARS 設備的需求。人口老化和肥胖率上升加劇了呼吸系統疾病和睡眠呼吸中止症的負擔,同時也增加了依賴安全麻醉護理的外科手術數量。
醫療系統正在對麻醉和監護設備進行現代化改造,使其與電子健康記錄系統對接,這促使設備更換時間和採購優先順序發生變化。在呼吸和睡眠治療領域,許多設備正從固定式轉向可攜式,以提高患者的舒適度、依從性和院外護理能力。
隨著醫療保健領域標準化程度的不斷提高,能夠將可靠的硬體與簡單的工作流程、數據連接和服務計劃相結合的供應商將佔有利地位。
市場促進因素
人口結構壓力。嬰兒潮世代如今已占美國人口的最大比例。據估計,40%的美國人患有肥胖症。這兩個趨勢將增加手術中麻醉的需求,以及需要呼吸支持和睡眠呼吸中止症治療的患者人數。
轉向居家和門診護理。可攜帶式氧氣設備、家用人工呼吸器、微型霧化器和正壓呼吸器將護理範圍擴展到了家庭。門診手術中心採用適合短期住院流程的麻醉監測和資訊系統。
科技日新月異。最新的麻醉機和人工呼吸器採用電子控制,操作精準便捷。睡眠治療和診斷設備不斷增加功能,以提高舒適度和患者依從性。行動應用程式和遠端監控功能則為指導、數據共用和後續隨訪提供了支援。
電子病歷整合和自動化。醫院程序傾向於支援自動化編程和文件記錄的設備,這推動了老舊麻醉機和監視器被可連接到排班和記錄系統的系統所取代。
公眾意識和檢測。儘管人們對睡眠呼吸中止症的認知正在提高,但許多重症病例仍未被診斷出來。支持居家睡眠檢測的政策可以提高診斷率,並使更多患者接受治療。
市場限制
高昂的購置和維護成本。麻醉機、人工呼吸器和資訊系統需要前期投資以及持續的訓練和服務。小型醫院和一些公共醫療機構預算有限,這可能會延遲更換。
患者依從性差。睡眠呼吸中止症和氧氣治療的長期治療需要持續使用。不適和不便會降低患者的依從性,並減少實際用藥量與臨床需求之間的差距。
集團採購競標定價和競標。集團採購組織壓縮價格分佈。耐用醫療設備競標計畫適用於睡眠和氧氣療法,導致報銷減少,並影響設備價格和醫療服務提供者的行為。
報銷壓力。家用氧氣及相關服務的報銷額度降低,導致供應商淨利率下降。政策變化也導致部分地區的氧氣供應商數量減少。
缺乏熟練人員。呼吸治療師、麻醉師和睡眠技師的短缺限制了服務擴張的速度,尤其是在大都會圈。
目標市場和數據範圍
量化指標:市場規模、市場佔有率、市場預測、成長率、銷售量、平均售價。
定性內容:市場成長趨勢、市場限制、主要競爭對手的競爭分析和 SWOT 分析、併購、公司簡介和產品系列、FDA 召回(如適用)、顛覆性技術、影響需求的疾病概況。
時限:基準年 2024 年,預測年 2025-2031 年,歷史資料 2021-2023 年。
資料來源:對行業領導者的直接訪談、政府醫生和程序資料、監管資料庫、私人醫院資料、進出口資料、iData Research 內部資料庫。
方法論收入模型採用單位乘以平均售價,並針對醫院和家庭環境的安裝基礎、使用率和政策影響檢驗。
目標市場及區隔
麻醉輸送單元(ADU)市場
透過設置地點:醫院手術室、其他醫院套房和門診手術中心。
麻醉監控器市場
依地點分類:醫院監視器、門診手術中心監視器。
麻醉資訊管理系統(AIMS)市場
依地點分類:醫院、門診手術中心。
拋棄式麻醉劑市場
依設備類型分類:麻醉管路、麻醉面罩、氣管插管、喉罩。
人工呼吸器市場
按設備類型分類:急性護理、亞急性護理、居家醫療、新生兒護理、非侵入性護理和緊急運輸。
霧化器市場
依設備類型:壓縮機或噴射式、振動式。
拋棄式呼吸防護設備市場
依設備類型分類:氧氣鼻導管、氧氣罩、氣切管、人工呼吸器、誘發性肺量計、熱濕交換器。
氧氣療法市場
依設備類型分類:氧氣濃縮機、氧氣輸送裝置、醫用鋁製氧氣瓶、居家醫療氧氣穩壓器、氧氣保護器和高流量鼻腔治療裝置。
阻塞型睡眠呼吸中止症症治療市場
依設備類型:正壓呼吸器、睡眠治療介面。
睡眠診斷設備市場
依設備類型:I 型、II 型、III 型、IV 型。
體外膜氧氣療法(ECMO)市場
依設備類型:機器、拋棄式。
競爭分析
瑞思邁在阻塞型睡眠呼吸中止症領域的優勢使其在2024年引領了整個ARS市場。該公司在睡眠診斷領域也佔有一席之地,並在人工呼吸器和呼吸拋棄式佔了相當可觀的佔有率。
飛利浦在麻醉監控器排名第二。該公司先前在人工呼吸器、阻塞性睡眠呼吸中止症、睡眠診斷和氧氣療法處於領先地位,但由於召回事件而退出了美國這些區隔市場。
CAIRE 是一家領先的氧氣濃縮機公司,擁有可攜式和可移動式氧氣濃縮器產品組合,並計劃在 2025 年推出固定式產品。
其他競爭對手正進軍麻醉、呼吸器、睡眠呼吸器、氧氣療法和拋棄式領域。產品組合的兼容性、服務網路和資料整合對於長期市場定位至關重要。
科技與臨床趨勢
可攜式易用的設備。制氧機和霧化器更輕、更簡單。 PAP系統和介面可提高舒適度,進而提高治療順從性。
數位化連接麻醉:現代麻醉單元和監視器的選擇是基於與 EMR 工作流程的易於整合性。
準備情況和現有設備。新冠疫情提高了人們對突波能力和感染控制的認知。雖然資本市場在最初的激增後已經調整,但在許多項目中,拋棄式的使用量仍然高於疫情前的水平。
居家睡眠檢測。政策支持居家檢測將擴大檢測範圍,使更多患者能夠接受治療。
治療地點
適用範圍涵蓋醫院、門診手術中心、相關醫生診所和居家醫療機構。護理地點的轉變會影響定價、產品選擇、物流和服務模式。供應商透過客製化套件、遠端監控選項和簡化的患者介面系統來應對這些差異。
地區
本報告涵蓋美國。
美國麻醉、呼吸和睡眠管理設備市場中規模最大、成長最快的機會是什麼?到 2031 年,哪些類別將為價值創造做出最大貢獻?
ARS 設備市場與美國更廣泛的經濟和醫療保健提供者運作(包括人員配備、報銷和臨床工作流程的數位轉型)有何關係?
未來哪些因素將影響市場格局,包括人口老化、肥胖、門診病人轉型、電子病歷整合、居家睡眠測試和緊急準備計畫?
政策和報銷如何影響價格和取得途徑,包括集團採購組織、耐久財競標計畫以及家庭氧氣療法和睡眠療法的支付變化。
哪些技術最有可能在醫院和家庭中廣泛應用,包括電子人工呼吸器、麻醉誘導設備、高流量鼻導管治療、PAP 呼吸機和睡眠介面,以提高舒適度和依從性?
供應商和服務提供者應如何規劃在家庭和門診環境中發揮越來越重要的作用,包括培訓、服務覆蓋範圍、設備便攜性以及與臨床醫生和看護者的數據共用?
鑑於睡眠檢測方式向家庭睡眠檢測轉變,以及需要有效地對患者進行分診以確定是否需要進行 PAP 治療和後續隨訪,睡眠診斷的前景如何?
哪些風險可能會減緩市場成長,例如報銷減少、勞動力短缺、依從性障礙以及區域供應商的財務狀況?
iData Research 發布的美國ARS 設備市場報告透過詳細的區隔和配置模型、企業市場占有率分析和定價來回答這些問題。
本報告可用於了解產品和醫療保健環境的需求,制定產品藍圖,使服務計畫與醫療保健提供者的限制保持一致,並設定定價、合約和庫存目標。
The U.S. anesthesia, respiratory and sleep management device market was valued at nearly $7 billion in 2024. The market is projected to grow to approach $9 billion over the forecast period.
This report covers anesthesia delivery units, anesthesia monitors, anesthesia information management systems, anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen therapy devices, therapeutic obstructive sleep apnea devices, sleep diagnostic devices, and extracorporeal membrane oxygenation (ECMO) systems.
Quantitative coverage includes unit sales, average selling prices, market size, growth rates, and company shares.
Qualitative coverage includes market drivers and limiters, mergers and acquisitions, product portfolios, recalls where relevant, and competitive positioning across hospitals, ambulatory surgery centers, and home care.
Market Overview
Demographic shifts and technology adoption continue to shape U.S. demand for ARS devices. An aging population and rising obesity rates increase the burden of respiratory disease and sleep apnea while also lifting surgical volumes that depend on safe anesthesia care.
Health systems have modernized anesthesia delivery and monitoring fleets to work with electronic medical record systems, which changed replacement timing and procurement priorities. In respiratory and sleep therapy, many devices are moving from stationary to portable formats to support comfort, adherence, and care outside the hospital.
Vendors that combine reliable hardware with simple workflows, data connectivity, and service programs are well positioned as providers standardize across sites of care.
Market Drivers
Demographic pressure. Baby boomers represent the largest share of the U.S. population. Obesity affects an estimated 40 percent of Americans. Both trends raise the need for anesthesia during surgery and increase the number of patients who require respiratory support and sleep apnea therapy.
Shift to home and outpatient care. Portable oxygen concentrators, home ventilators, compact nebulizers, and positive airway pressure devices extend therapy into the home. Ambulatory surgical centers adopt anesthesia monitoring and information systems that fit short stay workflows.
Advancing technology. Modern anesthesia delivery units and ventilators use electronic controls for precision and ease of use. Sleep therapy and diagnostic devices add features that improve comfort and adherence. Mobile apps and remote monitoring support coaching, data sharing, and follow up.
EMR integration and automation. Hospital programs favor devices that support auto programming and auto documentation. This reinforces replacement of older anesthesia delivery units and monitors with systems that can connect to scheduling and record keeping.
Public awareness and testing. Sleep apnea awareness is rising, yet many severe cases remain undiagnosed. Policies that favor home sleep testing increase access to diagnostics and feed more patients into therapy.
Market Limiters
High capital and maintenance costs. Anesthesia delivery units, ventilators, and information systems require upfront investment and ongoing training and service. Budget limits in small hospitals and some public facilities can delay replacement.
Patient non-adherence. Long term therapy for sleep apnea and oxygen requires consistent use. Discomfort or inconvenience reduces adherence, which lowers realized demand compared with the clinical need.
GPO pricing and competitive bidding. Group purchasing organizations compress price corridors. Durable medical equipment bidding programs apply to sleep and oxygen therapy and drive reimbursement reductions, which influence device prices and provider behavior.
Reimbursement pressure. Lower payments for home oxygen and related services reduce provider margins. Policy changes have reduced the number of oxygen suppliers in some regions.
Skilled personnel shortages. Shortages of respiratory therapists, anesthesia professionals, and sleep technologists limit the pace at which services can expand, especially outside major metro areas.
Market Coverage and Data Scope
Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
Qualitative coverage. Market growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, FDA recalls where applicable, disruptive technologies, and disease overviews that affect demand.
Time frame. Base year 2024, forecasts 2025 to 2031, historical data 2021 to 2023.
Data sources. Primary interviews with industry leaders, government physician and procedure data, regulatory databases, hospital private data, import and export data, and the iData Research internal database.
Method note. Revenue modeling uses units multiplied by ASP, validated against installed base, utilization, and policy impacts for hospital and home settings.
Markets Covered and Segmentation
Anesthesia Delivery Unit (ADU) Market
By setting. Hospital operating room, other hospital suite, ambulatory surgery center.
Anesthesia Monitor Market
By setting. Hospital monitor, ambulatory surgery center monitor.
Anesthesia Information Management System (AIMS) Market
By setting. Hospital, ambulatory surgery center.
Anesthesia Disposables Market
By device type. Anesthesia circuit, anesthesia mask, endotracheal tube, laryngeal mask.
Ventilator Market
By device type. Acute care, sub-acute care, home care, neonatal, non-invasive, emergency transport.
Nebulizer Market
By device type. Compressor or jet, vibrating.
Respiratory Disposables Market
By device type. Oxygen cannula, oxygen mask, tracheostomy tube, resuscitator, incentive spirometer, heat and moisture exchanger.
Oxygen Therapy Market
By device type. Oxygen concentrator, transfilling device, aluminum medical oxygen cylinder, medical oxygen regulator for home care, oxygen conserver, high flow nasal therapy device.
Therapeutic Obstructive Sleep Apnea Market
By device type. Positive airway pressure devices, sleep therapy interfaces.
Sleep Diagnostic Device Market
By device type. Type I, Type II, Type III, Type IV.
Extracorporeal Membrane Oxygenation (ECMO) Market
By device type. Machine, disposable.
Competitive Analysis
ResMed led the overall ARS market in 2024 on strength in obstructive sleep apnea. The company also participates in sleep diagnostics and holds a modest share in ventilators and respiratory disposables.
Philips ranked second on the basis of anesthesia monitors. It previously led in ventilators, OSA, sleep diagnostics, and oxygen therapy, but recall actions caused an exit from those U.S. segments.
CAIRE is a leading name in oxygen concentrators with portable and transportable lines and a stationary product launch in 2025.
Other competitors participate across anesthesia, ventilation, sleep, oxygen therapy, and disposables. Portfolio fit, service networks, and data integrations are important for long term positions.
Technology and Practice Trends
Portable and user friendly devices. Concentrators and nebulizers have become lighter and simpler. PAP systems and interfaces improve comfort to support adherence.
Digitally connected anesthesia. Modern ADUs and monitors are selected based on ease of integration with EMR workflows.
Preparedness and installed base. COVID-19 raised awareness of surge capacity and infection control. While capital markets reset after the initial spike, disposables use remains above pre-pandemic levels in many programs.
Home sleep testing. Policy support for home tests expands access and brings more patients into treatment.
Care Settings
Coverage spans hospitals, ambulatory surgery centers, physician offices where relevant, and home care. Shifts in site of care affect pricing, product selection, logistics, and service models. Vendors address these differences with tailored kits, remote monitoring options, and simple patient interfaces.
Geography
This edition covers the United States.
Where is the largest and fastest growing opportunity within the U.S. anesthesia, respiratory and sleep management device market and which categories contribute most to value creation through 2031.
How does the ARS device market relate to the broader U.S. economy and to provider operations, including staffing, reimbursement, and digital transformation of clinical workflows.
What forces will shape the market going forward, including aging, obesity, outpatient migration, EMR integration, home sleep testing, and preparedness planning.
How will policy and reimbursement affect price and access, including the impact of group purchasing organizations, durable medical equipment bidding programs, and payment changes for home oxygen and sleep therapy.
Which technologies have the clearest adoption path in hospitals and at home, including electronically controlled ventilators and anesthesia delivery units, high flow nasal therapy, PAP devices, and sleep interfaces that improve comfort and adherence.
How should providers and suppliers plan for the rising role of home and ambulatory settings, including training, service coverage, device portability, and data sharing with clinicians and caregivers.
What is the outlook for sleep diagnostics, given the shift to home sleep testing and the need to triage patients efficiently for PAP therapy and follow up.
Which risks could slow market growth, including reimbursement reductions, workforce shortages, adherence barriers, and the financial condition of regional providers.
The U.S. ARS device market report from iData Research answers these questions with segment and setting models, company share analysis, and pricing detail.
Use it to size demand by product and care setting, plan product roadmaps, align service programs with provider constraints, and set targets for pricing, contracting, and inventory.